Advances in the treatments of systemic vasculitides
- PMID: 18181034
- DOI: 10.1007/s12016-007-8068-4
Advances in the treatments of systemic vasculitides
Abstract
Necrotizing systemic vasculitides are severe diseases in which prognosis improved since steroids and cytotoxic agents have been prescribed. The outcome is now better, and remission is obtained in more than 80% of patients. In this review paper, we will cover the indications of conventional treatments and new biotherapies and other therapies. The strategies that improve patient's outcome are discussed in the light of the prospective trials organized by international research groups.
Similar articles
-
Therapeutic strategies for systemic necrotizing vasculitides.Allergol Int. 2007 Jun;56(2):105-11. doi: 10.2332/allergolint.R-07-144. Epub 2007 May 1. Allergol Int. 2007. PMID: 17460440 Review.
-
[Treatment of ANCA-associated vascularitides].Presse Med. 2007 May;36(5 Pt 2):922-7. doi: 10.1016/j.lpm.2007.01.029. Epub 2007 Apr 3. Presse Med. 2007. PMID: 17408912 Review. French.
-
Clinical review: Vasculitis on the intensive care unit -- part 2: treatment and prognosis.Crit Care. 2005 Apr;9(2):193-7. doi: 10.1186/cc2937. Epub 2004 Aug 18. Crit Care. 2005. PMID: 15774077 Free PMC article. Review.
-
[Treatment of systemic vasculitides].Rev Prat. 2008 Mar 15;58(5):541-4. Rev Prat. 2008. PMID: 18524111 Review. French.
-
[Treatment of pulmonary vasculitis].Rev Pneumol Clin. 1994;50(1):21-5. Rev Pneumol Clin. 1994. PMID: 7973327 Review. French.
Cited by
-
Clinical features and prognostic factors of Churg-Strauss syndrome.Korean J Intern Med. 2014 Jan;29(1):85-95. doi: 10.3904/kjim.2014.29.1.85. Epub 2014 Jan 2. Korean J Intern Med. 2014. PMID: 24574837 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical